Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05958901

Pulmonary Hypertension Observational Study

The purpose of this study is to establish the large PH cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pulmonary Hypertension Cardiovascular Diseases Hypertension Hypertension, Pulmonary Lung Diseases Respiratory Tract Diseases Vascular Diseases

Age range

20 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, 510000, China

Location status: Recruiting

Location contact

Zili Zhang, PHD

CONTACT

[email protected]

18922269968

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • PH group: When the mean pulmonary artery pressure is greater than 25mmHg at rest or greater than 30mmHg during exercise.
  • Signed informed consent obtained prior to participations with the ability to comply with protocol and be available for study visits over 5 years.

Exclusion criteria

  • Acute exacerbation in the past 3 months Having other respiratory diseases with massive lung tissue destruction such as severe bronchiectasis and tuberculosis, etc.
  • Serious uncontrolled diseases thoracic or abdominal surgery in the last 3 months.
  • Eye surgery in the last three months.
  • Retinal detachment myocardial infarction in the last 3 months.
  • Admission to hospital for any cardiac condition in the last month.
  • Heart rate over 120 beats per minute.
  • Antibacterial chemotherapy for tuberculosis pregnant or breast feeding.

Treatment and study plan

pulmonary hypertension

Other

The final outcome observed was a diagnosis of pulmonary hypertension.

Primary outcomes

  1. mean pulmonary arterial pressure

    Time frame: 12 months

    For an adult at sea level, when the mean pulmonary arterial pressure is greater than 25 mmHg at rest or greater than 30mmHg during exercise.

Sponsors and collaborators

Lead sponsor

The First Affiliated Hospital of Guangzhou Medical University

Other

Registry information

Official study title

A Observational Study in Chinese Patients With Pulmonary Hypertension (PH)

Important dates

Study start
2023
Primary completion
2025
Study completion
2027
First posted
Jul 25, 2023
Registry last updated
Jul 25, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.